DIVIS LABORATORIES
Back to Balance Sheet
|
DIVIS LABORATORIES Last 5 Year Short Term Loans and Advances History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Short Term Loans and Advances | ₹1,461 Cr | ₹1,156 Cr | ₹794 Cr | ₹715 Cr | ₹1,509 Cr |
What is the latest Short Term Loans and Advances ratio of DIVIS LABORATORIES ?
| Year | Short Term Loans and Advances |
|---|---|
| Mar2026 | ₹1,461 Cr |
| Mar2025 | ₹1,156 Cr |
| Mar2024 | ₹794 Cr |
| Mar2023 | ₹715 Cr |
| Mar2022 | ₹1,509 Cr |
How is Short Term Loans and Advances of DIVIS LABORATORIES Trending?
| Years | Short Term Loans and Advances | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,461 Cr | 26.38 | |
| Mar2025 | ₹1,156 Cr | 45.59 | |
| Mar2024 | ₹794 Cr | 11.05 | |
| Mar2023 | ₹715 Cr | -52.63 | |
| Mar2022 | ₹1,509 Cr | - | |
Compare Short Term Loans and Advances of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹218,997.7 Cr | -0.9% | 21.1% | 25.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,630.0 Cr | -0.1% | 0.5% | 14% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,358.0 Cr | -1.3% | 1.1% | 32.7% | Stock Analytics | |
| CIPLA | ₹118,916.0 Cr | 0.2% | 2.1% | -5.1% | Stock Analytics | |
| MANKIND PHARMA | ₹100,730.0 Cr | -1.4% | -3.7% | -5.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,824.0 Cr | 0.2% | -7.7% | -7.5% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | -0.9% |
21.1% |
25.6% |
| SENSEX | 0.5% |
2.6% |
-3.7% |
You may also like the below Video Courses